Literature DB >> 17242574

PET/CT staging and posttherapeutic monitoring of anaplastic thyroid carcinoma.

Ba D Nguyen1, Panol C Ram.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17242574     DOI： 10.1097/01.rlu.0000252240.35579.2c

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  3 in total

1.  18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer.

Authors:  Thomas Poisson; Désirée Deandreis; Sophie Leboulleux; François Bidault; Guillaume Bonniaud; Sylvain Baillot; Anne Aupérin; Abir Al Ghuzlan; Jean-Paul Travagli; Jean Lumbroso; Eric Baudin; Martin Schlumberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-06       Impact factor: 9.236

2.  Approach to the patient with anaplastic thyroid carcinoma.

Authors:  Robert C Smallridge
Journal:  J Clin Endocrinol Metab       Date:  2012-08       Impact factor: 5.958

3.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.